Travere Therapeutics Inc (NASDAQ:TVTX) price on Thursday, April 10, fall -5.99% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $13.49. A look at the stock’s price movement, the close in the last trading session was $14.35, moving
Travere Therapeutics Inc (NASDAQ:TVTX) price closed higher on Monday, April 07, and jumping 1.20% above its previous close. A look at the daily price movement shows that the last close reads $14.99, with intraday deals fluctuated between $13.97 and $15.83. The company’s 5Y monthly beta
Travere Therapeutics Inc (NASDAQ:TVTX) concluded the trading at $17.94 on Wednesday, April 03 with a rise of 2.87% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $17.44 and 5Y monthly beta
Travere Therapeutics Inc (NASDAQ:TVTX) traded at $18.27 at last check on current trade day and made a downward move of -7.16% on its previous day’s price. Looking at the stock we see that its previous close was $19.68 and the beta (5Y monthly) reads 0.751
Travere Therapeutics Inc (NASDAQ:TVTX) shares, rose in value on Thursday, March 27, with the stock price down by -2.02% to the previous day’s close as strong demand from buyers drove the stock to $20.37. Actively observing the price movement in the last trading, the stock
The trading price of Travere Therapeutics Inc (NASDAQ:TVTX) closed higher on current market day and closing at $21.29, 3.70% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $20.48 and $21.35. In examining the
Travere Therapeutics Inc (NASDAQ:TVTX) concluded the trading at $19.27 on Wednesday, March 12 with a rise of 6.32% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $18.12 and 5Y monthly beta
Travere Therapeutics Inc (NASDAQ:TVTX) traded at $17.68 at last check on current trade day and made a downward move of -2.24% on its previous day’s price. Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 77.53M, with a
Travere Therapeutics Inc (NASDAQ:TVTX) shares, rose in value on Thursday, March 06, with the stock price down by -2.42% to the previous day’s close as strong demand from buyers drove the stock to $18.94. Actively observing the price movement in the last trading, the stock
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
